Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy

Kenro Hirata, Hidekazu Suzuki, Juntaro Matsuzaki, Tatsuhiro Masaoka, Yoshimasa Saito, Toshihiro Nishizawa, Eisuke Iwasaki, Seiichiro Fukuhara, Sawako Okada, Toshifumi Hibi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The relationship between Helicobacter pylori {H. pylori) eradication therapy and the risk of developing gastroesophageal reflux disease (GERD) Is controversial. We investigated the influence of H. pylori eradication on the risk of GERD by focusing on the quality of life (QOL) and evaluating reflux symptoms. Patients with H. pylori infection were administered triple therapy for H. pylori eradication. At 3 months and 1 year after the eradication therapy, surveys were conducted to determine the health-related QOL by quality of life in reflux and dyspepsia-Japanese version, (QOLRAD-J) and the severity of GERD symptoms by Carlsson-Dent questionnaire (CDQ). Forty patients were included in the analysis. Although no significant changes of these scores were apparent 3 months after H. pylori eradication, the QOLRAD-J and CDQ scores were significantly improved after 1 year. The degree of improvement was even more marked in cases with initially low scores. In conclusion, improved GERD-related QOL and reflux symptoms were noted 1 year after H. pylori eradication therapy. In addition, the degree of improvement was more marked in cases with severe reflux symptoms.

Original languageEnglish
Pages (from-to)172-178
Number of pages7
JournalJournal of Clinical Biochemistry and Nutrition
Volume52
Issue number2
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Helicobacter pylori
Quality of Life
Gastroesophageal Reflux
Dyspepsia
Therapeutics
Health
Helicobacter Infections
Surveys and Questionnaires

Keywords

  • Eradication therapy
  • Helicobacter pylori
  • Quality of life
  • Questionnaire
  • Reflux symptoms

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy. / Hirata, Kenro; Suzuki, Hidekazu; Matsuzaki, Juntaro; Masaoka, Tatsuhiro; Saito, Yoshimasa; Nishizawa, Toshihiro; Iwasaki, Eisuke; Fukuhara, Seiichiro; Okada, Sawako; Hibi, Toshifumi.

In: Journal of Clinical Biochemistry and Nutrition, Vol. 52, No. 2, 01.03.2013, p. 172-178.

Research output: Contribution to journalArticle

@article{bc4dfc9d7865474da174b59f6244db6c,
title = "Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy",
abstract = "The relationship between Helicobacter pylori {H. pylori) eradication therapy and the risk of developing gastroesophageal reflux disease (GERD) Is controversial. We investigated the influence of H. pylori eradication on the risk of GERD by focusing on the quality of life (QOL) and evaluating reflux symptoms. Patients with H. pylori infection were administered triple therapy for H. pylori eradication. At 3 months and 1 year after the eradication therapy, surveys were conducted to determine the health-related QOL by quality of life in reflux and dyspepsia-Japanese version, (QOLRAD-J) and the severity of GERD symptoms by Carlsson-Dent questionnaire (CDQ). Forty patients were included in the analysis. Although no significant changes of these scores were apparent 3 months after H. pylori eradication, the QOLRAD-J and CDQ scores were significantly improved after 1 year. The degree of improvement was even more marked in cases with initially low scores. In conclusion, improved GERD-related QOL and reflux symptoms were noted 1 year after H. pylori eradication therapy. In addition, the degree of improvement was more marked in cases with severe reflux symptoms.",
keywords = "Eradication therapy, Helicobacter pylori, Quality of life, Questionnaire, Reflux symptoms",
author = "Kenro Hirata and Hidekazu Suzuki and Juntaro Matsuzaki and Tatsuhiro Masaoka and Yoshimasa Saito and Toshihiro Nishizawa and Eisuke Iwasaki and Seiichiro Fukuhara and Sawako Okada and Toshifumi Hibi",
year = "2013",
month = "3",
day = "1",
doi = "10.3164/jcbn.12-107",
language = "English",
volume = "52",
pages = "172--178",
journal = "Journal of Clinical Biochemistry and Nutrition",
issn = "0912-0009",
publisher = "The Society for Free Radical Research Japan",
number = "2",

}

TY - JOUR

T1 - Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy

AU - Hirata, Kenro

AU - Suzuki, Hidekazu

AU - Matsuzaki, Juntaro

AU - Masaoka, Tatsuhiro

AU - Saito, Yoshimasa

AU - Nishizawa, Toshihiro

AU - Iwasaki, Eisuke

AU - Fukuhara, Seiichiro

AU - Okada, Sawako

AU - Hibi, Toshifumi

PY - 2013/3/1

Y1 - 2013/3/1

N2 - The relationship between Helicobacter pylori {H. pylori) eradication therapy and the risk of developing gastroesophageal reflux disease (GERD) Is controversial. We investigated the influence of H. pylori eradication on the risk of GERD by focusing on the quality of life (QOL) and evaluating reflux symptoms. Patients with H. pylori infection were administered triple therapy for H. pylori eradication. At 3 months and 1 year after the eradication therapy, surveys were conducted to determine the health-related QOL by quality of life in reflux and dyspepsia-Japanese version, (QOLRAD-J) and the severity of GERD symptoms by Carlsson-Dent questionnaire (CDQ). Forty patients were included in the analysis. Although no significant changes of these scores were apparent 3 months after H. pylori eradication, the QOLRAD-J and CDQ scores were significantly improved after 1 year. The degree of improvement was even more marked in cases with initially low scores. In conclusion, improved GERD-related QOL and reflux symptoms were noted 1 year after H. pylori eradication therapy. In addition, the degree of improvement was more marked in cases with severe reflux symptoms.

AB - The relationship between Helicobacter pylori {H. pylori) eradication therapy and the risk of developing gastroesophageal reflux disease (GERD) Is controversial. We investigated the influence of H. pylori eradication on the risk of GERD by focusing on the quality of life (QOL) and evaluating reflux symptoms. Patients with H. pylori infection were administered triple therapy for H. pylori eradication. At 3 months and 1 year after the eradication therapy, surveys were conducted to determine the health-related QOL by quality of life in reflux and dyspepsia-Japanese version, (QOLRAD-J) and the severity of GERD symptoms by Carlsson-Dent questionnaire (CDQ). Forty patients were included in the analysis. Although no significant changes of these scores were apparent 3 months after H. pylori eradication, the QOLRAD-J and CDQ scores were significantly improved after 1 year. The degree of improvement was even more marked in cases with initially low scores. In conclusion, improved GERD-related QOL and reflux symptoms were noted 1 year after H. pylori eradication therapy. In addition, the degree of improvement was more marked in cases with severe reflux symptoms.

KW - Eradication therapy

KW - Helicobacter pylori

KW - Quality of life

KW - Questionnaire

KW - Reflux symptoms

UR - http://www.scopus.com/inward/record.url?scp=84875902789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875902789&partnerID=8YFLogxK

U2 - 10.3164/jcbn.12-107

DO - 10.3164/jcbn.12-107

M3 - Article

VL - 52

SP - 172

EP - 178

JO - Journal of Clinical Biochemistry and Nutrition

JF - Journal of Clinical Biochemistry and Nutrition

SN - 0912-0009

IS - 2

ER -